The Neosoma Platform
Neosoma's cloud platform is designed from the ground up to serve the multidisciplinary neuro-oncology clinical team, researchers and clinical trials.
​
A portfolio of highly-optimized, indication-specific software medical devices maps and measures compartments of tumors, and tracks lesions longitudinally, to deliver key insights in near-real-time to support clinical decisions and research.
​
Our technology is PACS-integrated, interoperable with radiation treatment and surgical planning systems, SOC2 Type II certified, HIPAA compliant, and web-based for easy and secure access.
​
Learn more about our capabilities below and schedule a demo to see how Neosoma can help your practice become even more efficient and effective.
Neosoma Cloud Platform:
One integrated solution for all tumor types
Fully-Featured and Adaptable
To Support Every Practice:
PACS Integrated
Neosoma's solution integrates with PACS to support automated sending of DICOM studies for analysis.
​
We also support one-click deep linking to jump from a timepoint in PACS directly to the same timepoint in Neosoma's system.
Efficient
Built for speed:
-
Per-timepoint and per-patient "gestalt" reports and summaries
-
Brain mets lesion review wizard
-
Smart editing tools
-
Quick visuals to show patients
MRI Protocol Tolerant
Neosoma's technology is highly tolerant of real-world data: No changes to MRI acquisition protocols are needed, and we readily accept prior patient studies.
Easy To Use
Be up and running with our intuitive, web-based interface in just a few minutes.
Secure
Neosoma's infrastructure is SOC2 Type II certified, HIPAA compliant, and was designed from the ground up to use best-in-class security practices.
Available Category 3 CPT Codes (0865T, 0866T) provide a reimbursement pathway for each MRI timepoint analysis, with or without a same-session diagnostic MRI.
Interactive
Neosoma's web application offers numerous interactive charts and reports to analyze longitudinal lesion data, as well as a suite of 3D and 2D visualizations, and smart segmentation / contour editing tools.
Interoperable
Easily import lesion contours (GTVs) into treatment planning systems such as Eclipse, MIM, Gamma Plan, Stealth, and others.
Scalable
Because Neosoma's platform is cloud-based, we can process a virtually unlimited number of patient MRIs (in total, as well as per patient), and can track all identified brain mets lesions.
Add Seats, Not Cost
Neosoma's solution is priced based on MRI volume, so each multidisciplinary team member can have a login to foster adoption and usage without worrying about incremental seat licenses.
Tumor Types
Neosoma's platform is currently FDA cleared for the following tumor types:
